Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
R428 is a small molecule inhibitor of Axl kinase, both in an in vitro biochemical assay and in a cell-based assay using phosphorylation of Ser473 on Akt as the readout (EC50s = 14 nM for both).1 It is orally bioavailable, blocks angiogenesis in corneal micropocket and tumor models, and reduces metastatic burden while extending survival in mouse models of breast cancer metastasis.1 R428 synergizes with cisplatin (Item No. 13119) to enhance suppression of liver micrometastasis.1 R428 is used to study the role of Axl kinase signaling in cancer, cellular senescence, and Zika virus infection.2,3,4
WARNING This product is not for human or veterinary use.
1. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Res. 70(4), 1544-1554 (2010).
2. AXL is a logical molecular target in head and neck squamous cell carcinoma. Clin. Cancer Res. 21(11), 2601-2612 (2015).
3. Gas6 delays senescence in vascular smooth muscle cells through the PI3K/ Akt/FoxO signaling pathway. Cell. Physiol. Biochem. 35(3), 1151-1166 (2015).
4. Axl mediates ZIKA virus entry in human glial cells and modulates innate immune responses. Cell Rep. 18(2), 324-333 (2017).